Otsuka Pharmaceutical

Graphic image of a red thumbs down against a blue background
Pharma

Otsuka, Lundbeck's Rexulti snubbed by FDA in PTSD

Otsuka and Lundbeck said the FDA will require new clinical trials if the partners wish to pursue a Rexulti PTSD approval in the future.
Fraiser Kansteiner Sep 22, 2025 4:42pm
Stop sign

FDA advisors overwhelmingly reject Lundbeck, Otsuka's PTSD drug

Jul 21, 2025 11:34am
newspaper

China biotech deals, Takeda, LaNova—Fierce Pharma Asia

Jul 18, 2025 9:04am
FDA

FDA questions Rexulti efficacy in PTSD after failed phase 3

Jul 16, 2025 2:38pm
Two businessmen pushing giant puzzle pieces together as the sun sets behind them

Otsuka forms joint venture to boost IV solution supply

Nov 14, 2024 8:40am
Otsuka

Otsuka falls foul of most serious drug marketing breach, again

Sep 30, 2024 9:31am